Should GP letter to patient/enhanced care versus treatment as usual (TAU) be used for people who self-harm?

Quality assessmentNo. of patientsEffectQualityImportance
No. of studiesDesignLimitationsInconsistencyIndirectnessImprecisionOther considerationsGP letter to patientTAURelative risk (95% CI)Absolute
Repetition of self-harm – during first 12 months
1Randomised trialsNo serious limitations--Serious1None211/964 (21.9%)189/968 (19.5%)RR 1.12 (0.94 to 1.34)23 more per 1000 (from 12 fewer to 66 more)--
-19.5%23 more per 1000 (from 12 fewer to 66 more)
Contact with services – during first 6 weeks
1Randomised trialsNo serious limitations--Serious1None351/599 (58.6%)387/681 (56.8%)RR 1.03 (0.94 to 1.13)17 more per 1000 (from 34 fewer to 74 more)--
-56.8%17 more per 1000 (from 34 fewer to 74 more)
1

Not statistically significant.

From: Appendix 17, GRADE evidence profiles

Cover of Self-Harm: Longer-Term Management
Self-Harm: Longer-Term Management.
NICE Clinical Guidelines, No. 133.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2012.
Copyright © 2012, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.